Less than 1 percent of cancers start in the heart, and disease that begins elsewhere seldom spreads to the blood-pumping ...

A novel bipolar conduction system pacing implantable cardioverter defibrillator lead demonstrated short-term safety and ...

Background Persistent shockable rhythms (refractory to or recurring after three or more defibrillation attempts) are ...

From understanding heart anatomy to mastering ECG interpretation, cardiovascular learning can be both high-yield and deeply practical. Using interactive tools, flashcards, and clinical case links ...

The saying "cold hands, warm heart" is usually meant metaphorically—but new research from UC Davis School of Medicine and ...

A dedicated bipolar implantable cardioverter-defibrillator (ICD) lead for conduction system pacing (CSP) performed well in a ...

Background Conduction system pacing (CSP) has emerged as an alternative to right ventricular pacing (RVP) for ...

Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm Society's annual conference (HRS 2026).

Pulse Biosciences, Inc. , developer of novel nPulsetm technology using proprietary Nanosecond Pulsed Field Ablationtm (nanosecond PFA or nsPFAtm) energy, today announced late-breaking positive ...

Abbott (NYSE: ABT) today announced new late-breaking data from four trials that demonstrate strong clinical outcomes within its pulsed field ablation (PFA) and conduction system pacing (CSP) ...

Doctors have been drilled for decades on the four big risks for heart disease, which kills more Americans every year than any other illness. The fearsome foursome: hypertension, smoking, high levels ...

A 173-patient randomized trial in HFrEF (LVEF ≤35%) with LBBB (QRS ≥130 ms) showed CSP was inferior to BiVP for a hierarchical 12‑month composite endpoint. Worse outcomes with CSP were reflected by an ...